By Fineline Cube 
China-based Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392) announced that its Tuberculosis infection T cell detection kit has been included in the StopTB Partnership procurement list managed by the United Nations Office for Project Services (UNOPS). This marks a significant milestone in the global fight against tuberculosis (TB).
StopTB Partnership Overview
The Stop TB Partnership, founded in 2001 and hosted by the United Nations, is dedicated to serving the needs of individuals and communities affected by TB. The organization takes bold and smart risks to amplify the voices of those impacted by the disease and drive progress toward its elimination.
WHO Recommendation and UNOPS Agreement
Wantai Bio’s Tuberculosis infection T cell detection kit was recommended by the World Health Organization (WHO) in 2022 for detecting Mycobacterium tuberculosis infection. Following this recommendation, UNOPS entered into a long-term supply agreement with Wantai Bio, ensuring the availability of this critical diagnostic tool for countries and communities in need.-Fineline Info & Tech